We are live on
!
Find out more
B
BP Portfolio holdings
AUM
$17.7M
1-Year Est. Return
12.34%
This Fund
S&P 500
This Quarter
Est. Return
+14.78%
1 Year Est. Return
+12.34%
3 Year Est. Return
+57.04%
5 Year Est. Return
+25.97%
10 Year Est. Return
+282.85%
AUM
$2.58B
AUM Growth
+$169M
(+7%)
Cap. Flow
-$137M
Cap. Flow
% of AUM
-5.3%
Top 10 Holdings %
Top 10 Hldgs %
20.48%
Holding
473
New
45
Increased
36
Reduced
58
Closed
91
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Baxter International
BAX
|
+$7.35M |
| 2 |
Analog Devices
ADI
|
+$6.02M |
| 3 |
Linde
LIN
|
+$5.98M |
| 4 |
3M
MMM
|
+$5.03M |
| 5 |
S&P Global
SPGI
|
+$4.94M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$11.5M |
| 2 |
Cigna
CI
|
+$8.08M |
| 3 |
Union Pacific
UNP
|
+$7.4M |
| 4 |
Costco
COST
|
+$7.22M |
| 5 |
CSX Corp
CSX
|
+$7.02M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.03% |
| 2 | Financials | 14.73% |
| 3 | Healthcare | 14.16% |
| 4 | Communication Services | 10.23% |
| 5 | Consumer Discretionary | 9.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
Resideo Technologies
REZI
$5.16B
| $296K | 0.01% |
15,366
| – | – |
|
377
Antero Resources
AR
$10.9B
| $248K | 0.01% |
+28,070
| New | +$265K |
|
|
CVET
378
DELISTED
Covetrus, Inc. Common Stock
CVET
| $242K | 0.01% |
+7,600
| New | +$270K |
|
379
Ambev
ABEV
$47.7B
| – | – |
-804,460
| Closed | -$3.15M |
|
380
Archer Daniels Midland
ADM
$41.6B
| – | – |
-65,000
| Closed | -$2.66M |
|
381
Assurant
AIZ
$13.6B
| – | – |
-6,000
| Closed | -$536K |
|
382
Align Technology
ALGN
$12B
| – | – |
-8,000
| Closed | -$1.68M |
|
383
Alaska Air
ALK
$4.99B
| – | – |
-58,000
| Closed | -$3.53M |
|
384
Ashland
ASH
$3.05B
| – | – |
-8,000
| Closed | -$567K |
|
385
Acuity Brands
AYI
$9.79B
| – | – |
-5,400
| Closed | -$621K |
|
386
BioMarin Pharmaceuticals
BMRN
$11.4B
| – | – |
-19,000
| Closed | -$1.62M |
|
387
Broadridge
BR
$16.7B
| – | – |
-14,000
| Closed | -$1.35M |
|
388
BorgWarner
BWA
$13.2B
| – | – |
-27,264
| Closed | -$834K |
|
389
Cardinal Health
CAH
$52.9B
| – | – |
-34,000
| Closed | -$1.52M |
|
390
CF Industries
CF
$19.5B
| – | – |
-25,000
| Closed | -$1.09M |
|
391
Citizens Financial Group
CFG
$30.3B
| – | – |
-50,000
| Closed | -$1.49M |
|
392
C.H. Robinson
CHRW
$24.2B
| – | – |
-17,000
| Closed | -$1.43M |
|
|
393
Cigna
CI
$75.7B
| – | – |
-42,524
| Closed | -$8.08M |
|
|
CMA
394
DELISTED
Comerica
CMA
| – | – |
-18,000
| Closed | -$1.24M |
|
395
Cencora
COR
$59.4B
| – | – |
-18,000
| Closed | -$1.34M |
|
|
396
CVS Health
CVS
$136B
| – | – |
-176,182
| Closed | -$11.5M |
|
397
Delta Air Lines
DAL
$53.9B
| – | – |
-20,000
| Closed | -$998K |
|
|
DFS
398
DELISTED
Discover Financial Services
DFS
| – | – |
-35,000
| Closed | -$2.06M |
|
399
HF Sinclair
DINO
$16.1B
| – | – |
-17,000
| Closed | -$869K |
|
400
Domino's
DPZ
$10.7B
| – | – |
-5,000
| Closed | -$1.24M |
|
Similar funds
CP
BCPE
AE
SCTC
HIM
MPW
LPC
PA
BP's Q1 2019 Portfolio in Review
As of Q1 2019, BP held 473 positions worth $2.58B, up 7% from $2.41B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
BP withdrew a net $137M in Q1 2019, closing 91 positions and reducing 58 holdings. Its most notable exit was CVS Health, an estimated $11.5M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.
Against the trend, BP opened a new position in S&P Global worth $5.37M.
- BP's largest Q1 2019 buy was S&P Global: 25,500 shares worth $5.37M.
- BP added most to Baxter International in Q1 2019, an estimated $7.35M increase.
- BP's biggest Q1 2019 reduction was Union Pacific, cutting an estimated $7.4M.
- BP fully exited CVS Health in Q1 2019, selling an estimated $11.5M.
- BP's ten largest holdings make up 20% of its $2.58B portfolio in Q1 2019.
- BP opened 45 new positions and closed 91 in Q1 2019.
- BP's portfolio value rose 7% quarter-over-quarter to $2.58B.
Based on BP's 13F filing for Q1 2019, filed 8 May 2019.